Evidence map›Paper›PMID 42371058›Full record

ArticleAnalytical and bioanalytical chemistry2026

A controllable glycosyl molecularly imprinted strategy on MOF nanozyme for high-specificity colorimetric detection of CA19-9.

Zhenghong Zhao, Shuzhen Xu, Yue Xu, Guoming Liao, Changbing Pan, Lianming Zhang, Fanggui Ye, Jianping Li

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhenghong ZhaoCollege of Environmental Science and Engineering, Guilin University of Technology, Guilin, 541004, Guangxi, China.
Shuzhen XuCollege of Chemistry and Bioengineering, Guilin University of Technology, Guilin, 541004, Guangxi, China.
Yue XuCollege of Chemistry and Bioengineering, Guilin University of Technology, Guilin, 541004, Guangxi, China.
Guoming LiaoCollege of Chemistry and Bioengineering, Guilin University of Technology, Guilin, 541004, Guangxi, China.
Changbing PanCollege of Chemistry and Bioengineering, Guilin University of Technology, Guilin, 541004, Guangxi, China.
Lianming ZhangCollege of Environmental Science and Engineering, Guilin University of Technology, Guilin, 541004, Guangxi, China.
Fanggui YeSchool of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin, 541004, China. fgye@gxnu.edu.cn.
Jianping LiCollege of Environmental Science and Engineering, Guilin University of Technology, Guilin, 541004, Guangxi, China. likianping@263.net.

Funding

Scientific Research Startup Foundation of Guilin University of Technology GUTQDJJ2024060the National Natural Science Foundation of China 22564010the National Natural Science Foundation of China No. 22264010
6 · The paper itself

Abstract

Molecularly imprinted nanozymes (MINs) offer a compelling alternative to antibody-based assays by integrating specific molecular recognition with enzyme-like catalytic activity. Nevertheless, conventional molecular imprinting of glycoproteins remains technically challenging. In this work, employing CA19-9 as a model glycoprotein biomarker, we develop a surface-directed glycan imprinting strategy by integrating molecular imprinting technology with iron-based metal-organic framework (MIL-88B-NH

Indexed as

Antigens, Tumor-Associated, CarbohydrateCA-19-9 AntigenColorimetryMetal-Organic FrameworksMolecular ImprintingNanostructuresHumansLimit of DetectionAntigens, Tumor-Associated, CarbohydrateCA-19-9 Antigencarbohydrate antigen 199, humanMetal-Organic FrameworksCA19-9Colorimetric sensorMetal-organic frameworkMolecularly imprinted nanozymeSynergistic recognition-catalysis

Identifiers

PMID42371058

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.